{{Rsnum
|rsid=16886165
|Chromosome=5
|position=56727256
|Orientation=plus
|GMAF=0.2383
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 3.5 | 25.7 | 70.8
| HCB | 12.4 | 42.3 | 45.3
| JPT | 8.8 | 45.1 | 46.0
| YRI | 10.2 | 49.0 | 40.8
| ASW | 12.3 | 42.1 | 45.6
| CHB | 12.4 | 42.3 | 45.3
| CHD | 11.9 | 45.9 | 42.2
| GIH | 11.9 | 35.6 | 52.5
| LWK | 9.1 | 45.5 | 45.5
| MEX | 1.7 | 29.3 | 69.0
| MKK | 7.7 | 30.1 | 62.2
| TSI | 2.9 | 24.5 | 72.5
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19330030
|Trait=Breast cancer
|Title=A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)
|RiskAllele=G
|Pval=5E-7
|OA=1
}}

{{PharmGKB
|RSID=rs16886165
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19330030; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A multistage genome-wide association study in Breast Cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). (Initial Sample Size: 1,145 cases, 1,142 controls; Replication Sample Size: 8,625 cases, 9,657 controls); (Region: 5q11.2; Reported Gene(s): MAP3K1; Risk Allele: rs16886165-G); (p-value= 0.0000005).This variant is associated with Breast Cancer.
|Drugs=
|Drug Classes=
|Diseases=Breast Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164739882
}}

{{PMID Auto
|PMID=22452962
|Title=A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs16886165
|overall_frequency_n=36
|overall_frequency_d=128
|overall_frequency=0.28125
|n_genomes=28
|n_genomes_annotated=0
|n_haplomes=34
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto
|PMID=22965832
|Title=Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}